Vorolanib by Betta Pharmaceuticals for Thymic Carcinoma: Likelihood of Approval

Vorolanib is under clinical development by Betta Pharmaceuticals and currently in Phase II for Thymic Carcinoma.

Natural Medicine Advisory Bulletin #4: September 2023 – Psychedelic Alpha

*** One new non-voting participant was introduced in the September meeting of the Qualifications, Licensing, and Training subcommittee. The new participant, Luke Priel, is a

October 11, 2023

Strategies and innovations for reducing drug product loss in sterile filling – Pharmaceutical Technology

Share this article Credit: Shutterstock Sterile filling is a critical step in pharmaceutical primary packaging; the transfer of sterile drug product into its final primary

December 7, 2023

Digital Health Apps Can Legally Sell Your Health Data

What You Should Know: ClearDATA®, the first and most comprehensive provider of healthcare-specific managed cloud, compliance and defense services, recently announced the results of its Digital

July 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.